Labetalol Hydrochloride

규격

32780-64-6CAS 번호

276-694-6EC 번호

2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochlorideIUPAC 명칭

C19H25ClN2O3화학식

364.9 g/mol분자량

Labetalol hydrochloride; 32780-64-6; Labetalol HCL; Labrocol; ScH 15719W; AH 5158A; Ibidomide hydrochloride; Sch-15719W; DTXSID0044654; 1GEV3BAW9J; AH-5158A; NSC-290312; AH-5158A HYDROCHLORIDE; SCH-15719W HYDROCHLORIDE; DTXCID8024654; NSC290312; 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride; Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride; 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride; Labetalol Hydrocloride; Hydrochloride, Labetalol; RefChem:58511; Labetalol HCl in Dextrose; Labetalol HCl in Sodium Chloride; LABETALOL HYDROCHLORIDE IN DEXTROSE; LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE; 2-Hydroxy-5-((1RS)-1-hydroxy-2-((1RS)-1-methyl-3-phenylpropylamino)ethyl)benzamide monohydrochloride 2-Hydroxy-5-((1RS)-1-hydroxy-2-((1SR)-1-methyl-3-phenylpropylamino)ethyl)benzamide monohydrochloride; 251-211-1; Amipress; Normodyne; Presdate; Trandate; Labetalol (hydrochloride); 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride; Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1); MFCD00057663; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride; MLS000069666; Labetalol (hydrochloride) (Standard); AH-5158 hydrochloride;Sch-15719W; Pressalolo; SMR000058463; Ipolab; 72487-34-4; rac-Labetalol Hydrochloride; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride; 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride; 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide hydrochloride; 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride; CCRIS 1086; SR-01000000209; EINECS 251-211-1; UNII-1GEV3BAW9J; NSC 290312; 32780-64-6 (HCl); 2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride; 2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide hydrochloride; Normodyne (TN); Trandate (TN); Prestwick_290; EINECS 276-694-6; Labeolol hydrochloride; Labetalol hydrochloride [USAN:USP:JAN]; La.beta.lol hydrochloride; Opera_ID_1625; Benzamide,monohydrochloride; NCGC00016810-01; Salicylamide, hydrochloride; Labetalol hydrochloride CRS; CAS-32780-64-6; Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride; SCHEMBL41230; MLS001148626; MLS002222197; SPECTRUM1503243; CHEBI:6344; orb1225302; orb1310699; CHEMBL1200323; SCHEMBL29710409; HY-B1108R; GLXC-06704; HMS1568H16; HMS1922M13; HMS5083I05; MSK000466A; Pharmakon1600-01503243; EX-A4940; HY-B1108; LABETALOL HYDROCHLORIDE [MI]; Tox21_110623; Tox21_302725; Tox21_500687; CCG-40314; EBC-80148; Labetalol hydrochloride (JP18/USP); LABETALOL HYDROCHLORIDE [JAN]; NSC758438; s4291; LABETALOL HYDROCHLORIDE [USAN]; AKOS015895575; AC-1389; AH-5158; CS-4706; FL61512; LABETALOL HYDROCHLORIDE [MART.]; LABETALOL HYDROCHLORIDE [VANDF]; LP00687; MSK000466A-1000M; NC00571; NSC-758438; SS-4219; LABETALOL HYDROCHLORIDE [USP-RS]; LABETALOL HYDROCHLORIDE [WHO-DD]; NCGC00094044-01; NCGC00094044-02; NCGC00094044-03; NCGC00094044-04; NCGC00094044-05; NCGC00256847-01; NCGC00261372-01; (R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride; DB-048265; CS-0694914; EU-0100687; LABETALOL HYDROCHLORIDE [ORANGE BOOK]; NS00087824; SW196595-3; LABETALOL HYDROCHLORIDE [EP MONOGRAPH]; D00600; LABETALOL HYDROCHLORIDE [USP MONOGRAPH]; Labetalol hydrochloride, >98% (TLC), powder; NORMOZIDE COMPONENT LABETALOL HYDROCHLORIDE; SR-01000000209-2; SR-01000000209-7; Q27252396; Labetalol hydrochloride Solution in Methanol, 1000ug/mL; 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl; Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard; Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride; Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide--hydrogen chloride (1/1); Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1); Mixture of 4 stereoisomers of 2-hydroxy-5-[1-hydroxy2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride동의어